Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age
NCT03286049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2018-11-16
Summary
Longitudinal, observational study to assess the short-term (test re-test) and mid-term (within the span of 28 days) repeatability of active anterior rhinomanometry (AAR) measures on 4 parallel groups of children with different rhinitis phenotypes, and 1 group of control (healthy) children.
Secondary objectives are: i) assessing of association between AAR, exhaled FeNO (eFeNO) and nasal FeNO (nFeNO); ii) assessing association between objective measurements (AAR, eFeNO and nFeNO) and subjective measurements (Total 5 Symptom score, T5SS).
The study is intended to obtain useful information for improving rhinitis management.
Conditions
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Seasonal
- Rhinitis, Allergic, Perennial
Sponsors & Collaborators
-
Istituto per la Ricerca e l'Innovazione Biomedica
lead OTHER
Eligibility
- Min Age
- 10 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-10
- Primary Completion
- 2018-07-31
- Completion
- 2018-07-31
Countries
- Italy
Study Locations
More Related Trials
-
Study on Association Between Treatment of Allergic Rhinitis and Cognitive Ability in Children
NCT03714945 ·Status: UNKNOWN
-
The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
NCT01318954 ·Status: COMPLETED
-
The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy
NCT04544774 ·Status: RECRUITING
-
Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis
NCT00952835 ·Status: UNKNOWN
-
Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects
NCT06459219 ·Status: NOT_YET_RECRUITING
-
Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis
NCT01085526 ·Status: COMPLETED ·Phase: NA
-
Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases
NCT00815984 ·Status: COMPLETED
-
The Effect of Allergic Rhinitis on Educational Outcomes
NCT05881577 ·Status: UNKNOWN
-
Implementation of an Allergic Rhinitis Severity Questionnaire in ENT Consultations
NCT07315945 ·Status: RECRUITING
-
Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study
NCT06778213 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of Nasal Inflammatory Biomarkers
NCT03450031 ·Status: COMPLETED ·Phase: NA
-
App Based Study on the Symptoms of Patients With Allergic Rhinitis in the Pollen Season
NCT03112252 ·Status: COMPLETED
-
Observational Study of Allergic Rhinitis in Children
NCT05655858 ·Status: COMPLETED
-
Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis
NCT03649139 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of Laser Doppler Flowmetry to Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations in Histamine Metabolism
NCT00362999 ·Status: COMPLETED
-
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
NCT02230475 ·Status: COMPLETED
-
A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
NCT07091357 ·Status: RECRUITING ·Phase: PHASE2
-
Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma
NCT05476484 ·Status: UNKNOWN
-
Effect of Intralymphatic Immunotherapy
NCT02255604 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis
NCT04071249 ·Status: COMPLETED
-
Validation of an Allergic Rhinitis Control Test in Teenagers
NCT02818153 ·Status: UNKNOWN ·Phase: NA
-
Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis
NCT03157505 ·Status: COMPLETED ·Phase: PHASE3
-
Examination of the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma Severity
NCT00584051 ·Status: TERMINATED
-
Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)
NCT06603935 ·Status: ENROLLING_BY_INVITATION ·Phase: NA